HHSN261201500003I; HHSN26100069; 400.012.0069.0001; NCI CCG; appropriated; master trial in lymphoma (masterlymph), moonshot; 09/28/2018-09/27/2023
Ended Awarded Last action
- Contract number
- 75N91018F00069
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,378,995
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 27% obligated
- $5,067,705.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,378,995 |
Show all 17
About this award
This is a $5,067,705.00 delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for the Master Trial in Lymphoma (MASTERLYMPH), which is part of the National Cancer Institute's Cancer Moonshot initiative. The contract has a period of performance from September 28, 2018 to September 27, 2023 and is a cost-plus-fixed-fee type contract. There is no set-aside designation for this award. Leidos Biomedical Research has previously performed a range of biomedical research and support services for the NIH, including facilities operations and maintenance, research and development, manufacturing, and clinical trials management.
Quick answers
Who was awarded contract 75N91018F00069?
75N91018F00069 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 28, 2018.
How much is contract 75N91018F00069 worth?
The government has obligated $1,378,995 on 75N91018F00069. Its current value, with exercised options, is $5,067,705.
Is contract 75N91018F00069 an order under another contract?
Yes. 75N91018F00069 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00069 competed?
The extent of competition for 75N91018F00069 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award